Mulvihill US Health Care Enhanced Yield ETF (XLVE)
TSX
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
CAD ($) | CAD ($) | |
Return on Assets (%) | N/A | -15.605 |
Return on Equity (%) | N/A | -15.822 |
Return on Invested Capital (%) | N/A | -15.822 |
Operating Margin (%) | N/A | N/A |
Net Profit Margin (%) | N/A | N/A |
Book Value Per Share | N/A | N/A |
Earnings Per Share | N/A | N/A |
Cash Per Share | N/A | N/A |
Working Capital Per Share | N/A | N/A |
Operating Profit Per Share | N/A | N/A |
EBIT Per Share | N/A | N/A |
EBITDA Per Share | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
Current Ratio | N/A | N/A |
Quick Ratio | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A |
Shares Outstanding | N/A | N/A |
Market Cap | 0 |
Price to Earnings Ratio | 0 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 0 |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.